维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Lebray"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Applicability and variability of liver stiffness measurements according to probe position显示文摘AIM: To investigate the liver stiffness measurement (LSM) applicability and variability with reference to three probe positions according to the region of liver biopsy. METHODS: The applicability for LSM was defined as at least 10 valid measurements with a success rate greater than 60% and an interquartile range/median LSM < 30%. The LSM variability compared the inter-position concordance and the concordance with FibroTest. RESULTS: Four hundred and forty two consecutive patients were included. The applicability of the anterior position (81%) was significantly higher than that of the reference (69%) and lower positions (68%), (both P = 0.0001). There was a signif icant difference (0.5 kPa, 95% CI 0.13-0.89; P < 0.0001) between mean LSM estimated at the reference position (9.3 kPa) vs the anterior position (8.8 kPa). Discordance between positions was associated with thoracic fold (P = 0.008). The discordance rate between the reference position result and FibroTest was higher when the 7.1 kPa cutoff was used to define advanced fibrosis instead of 8.8 kPa (33.6% vs 23.5%, P = 0.03).CONCLUSION: The anterior position of the probe should be the fi rst choice for LSM using Fibroscan, as it has a higher applicability without higher variability compared to the usual liver biopsy position.	Patrick Ingiliz Kim Pav Chhay Mona Munteanu Pascal Lebray Yen Ngo Dominique Roulot Yves Benhamou Dominique Thabut Vlad Ratziu Thierry Poynard	2009	World Journal of Gastroenterology2009，15，27：	5
2	Prognostic value of liver fibrosis and steatosis biomarkers in type‐2 diabetes and dyslipidaemia显示文摘	H. Perazzo M. Munteanu Y. Ngo P. Lebray N. Seurat F. Rutka M. Couteau S. Jacqueminet P. Giral D. Monneret F. Imbert‐Bismut V. Ratziu A. Hartemann‐Huertier C. Housset T. Poynard	2014	Aliment Pharmacol Ther2014，，9：	3
3	A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver显示文摘	Raluca Pais Fréderic Charlotte Larissa Fedchuk Pierre Bedossa Pascal Lebray Thierry Poynard Vlad Ratziu	2013	Journal of Hepatology2013，，：	2
4	Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard显示文摘	Thierry Poynard Mona Munteanu Elena Luckina Hugo Perazzo Yen Ngo Luca Royer Larysa Fedchuk Florence Sattonnet Raluca Pais Pascal Lebray Marika Rudler Dominique Thabut Vlad Ratziu	2013	Journal of Hepatology2013，，5：	2
5	A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver<!-- Doctopic: GMD -->显示文摘	Raluca Pais Fréderic Charlotte Larissa Fedchuk Pierre Bedossa Pascal Lebray Thierry Poynard Vlad Ratziu	2013	Journal of Hepatology2013，，：	2
6	Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest?) and transient elastography (FibroScan?)显示文摘	Thierry Poynard Julien Vergniol Yen Ngo Juliette Foucher Mona Munteanu Wassil Merrouche Massimo Colombo Vincent Thibault Eugene Schiff Clifford A. Brass Janice K. Albrecht Marika Rudler Olivier Deckmyn Pascal Lebray Dominique Thabut Vlad Ratziu Victor de	2013	Journal of Hepatology2013，，：	2
7	Liver stiff- ness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency 显示文摘	LEBRAY P VAMOUS S CHARLOTTE F	2008	Hepatology2008，48，6：	1
8	Progression of liver fibrosis in women infected with hepatitis C : long-term benefit of estrogen exposure显示文摘	Di-Martino V Lebray P Myers R P	2004	Hepatology2004，40，6：	1
9	Natural history and predictors of disease severity in chronic hepatitis C显示文摘	Julien Massard Vlad Ratziu Dominique Thabut Joseph Moussalli Pascal Lebray Yves Benhamou Thierry Poynard		Journal of Hepatology0，，：	1
10	Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes 显示文摘	Jacqueminet S Lebray P Morra R	2008	Clin Gas- troemerol Hepatol2008，6，7：	1
11	HIV infection and hepatic enzyme abnormalities:intricacies of the pathogenic mechanisms显示文摘	Pol S Lebray P Vallet-Pichard A	2004	Clin Infect Dis2004，38，：	1
12	Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants显示文摘	Kamar N Garrouste C Haagsma E B Garrigue V Pischke S Chauvet C Dumortier J Cannesson A Cassuto-Viguier E Thervet E Conti F Lebray P Dalton H R Santella R Kanaan N Essig M Mousson C Radenne S Roque-Afonso A M Izopet J Rostaing L	2011	Gastroenterology2011，140，5：	1
13	Natural history and predictors of disease severity in chronic hepatitis C显示文摘	Julien Massard Vlad Ratziu Dominique Thabut Joseph Moussalli Pascal Lebray Yves Benhamou Thierry Poynard	2005	Journal of Hepatology2005，，：	1
14	Ribavirin for chronic hepatitis E virus infection in transplant recipients显示文摘	Kamar N Izopet J Tripon S Bismuth M Hillaire S Dumortier J Radenne S Coilly A Garrigue V D'alteroche L Buchler M Couzi L Lebray P Dharancy S Minello A Hourmant M Roque-Afonso A M Abravanel F Pol S Rostaing L Mallet V	2014	N Engl J Med2014，370，12：	1
15	A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver显示文摘	Raluca Pais Fréderic Charlotte Larissa Fedchuk Pierre Bedossa Pascal Lebray Thierry Poynard Vlad Ratziu	2013	Journal of Hepatology2013，，3：	1
16	Prevalence of mixed cryoglobulins in relation to CD4 cell count among patients coinfected with HIV and hepatitis C virus显示文摘	Aaron L Lebray P Alyanakian MA	2005	Clin Infect Dis2005，40，2：	1
17	NNRTI-related or unrelated hepatotoxicity?显示文摘	Lebray P Benhamou Y Pol S	2002	Hepatology2002，36，：	1
18	Factors Associated With Chronic Hepatitis in Patients With Hepatitis E Virus Infection Who Have Received Solid Organ Transplants显示文摘	Nassim Kamar Cyril Garrouste Elizabeth B. Haagsma Valérie Garrigue Sven Pischke Cécile Chauvet Jérome Dumortier Amélie Cannesson Elisabeth Cassuto–Viguier Eric Thervet Filomena Conti Pascal Lebray Harry R. Dalton Robert Santella Nada Kanaan Marie Essig Ch	2011	Gastroenterology2011，，5：	1
19	A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver<.-- Doctopic: GMD -->显示文摘	Raluca Pais Fréderic Charlotte Larissa Fedchuk Pierre Bedossa Pascal Lebray Thierry Poynard Vlad Ratziu	2013	Journal of Hepatology2013，，：	1
20	Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency显示文摘	Lebray P Varnous S Charlotte F	2008	Hepatology2008，48，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示